demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
CanSino (Convidecia) Li J NCT04540419 CanSino phase 3 CanSino phase 2 ... Fengcai

0 studies excluded by filtering options 1